ContributorsPublishersAdvertisers

InMed Pharmaceuticals Inc. Announces Completion of BayMedica Acquisition

Benzinga
Benzinga
 2021-10-15
Cover picture for the article

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. INM had announced the acquisition...

www.benzinga.com

Comments / 0

Comments / 0